Pfizer to acquire obesity-drug maker Metsera for $4.9 bn | News

NEW YORK, Sept 22, 2025 (BSS/AFP) - US pharmaceutical giant Pfizer willacquire Metsera, a maker of drugs for obesity and heart disease, for $4.9billion, the companies said Monday. With the purchase Pfizer aims to broaden its portfolio and enter...